Low-Dose OnabotulinumtoxinA using Seven-Point Pattern Intradermal Injections in Patients with Moderate-to-intolerable Primary Axillary Hyperhidrosis: A Single-Blinded, Side-by-Side Randomized Trial
June 1, 2023
J Clin Aesthet Dermatol. 2023;16(6):37–43. by Doungkamol Siri-archawawat, MD and Weeratian Tawanwongsri, MD Dr. Siri-Archawawat is with the Division of Neurology, Department of Internal Medicine, and School of Medicine at
